ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price was up 6% on Friday. The stock traded as high as $1.0625 and last traded at $1.06. Approximately 182,431 shares traded hands during mid-day trading, an increase of 797% from the average session volume of 20,327 shares. The stock had previously closed at $1.00.
ImmunoPrecise Antibodies Stock Down 1.0%
The company has a 50 day moving average of $1.28 and a two-hundred day moving average of $1.36.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. is a biotechnology company focused on antibody discovery and development. The company combines artificial intelligence and machine learning with laboratory-based methods to identify and optimize antibodies for research, diagnostic and therapeutic applications. Its services include antibody discovery, engineering, humanization, expression, production and characterization. ImmunoPrecise offers several discovery platforms, including B-cell and display-based technologies, as well as computational tools designed to help analyze antibody candidates and guide the development of molecules with desired binding and functional properties.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
